These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 30112050

  • 1. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocarcinogenesis via modulating TGF-β/TβR and Imp7/8.
    Wu C, Kan H, Hu M, Liu X, Boye A, Jiang Y, Wu J, Wang J, Yang X, Yang Y.
    Exp Ther Med; 2018 Aug; 16(2):1052-1060. PubMed ID: 30112050
    [Abstract] [Full Text] [Related]

  • 2. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A, Wu C, Jiang Y, Wang J, Wu J, Yang X, Yang Y.
    J Ethnopharmacol; 2015 Jul 01; 169():219-28. PubMed ID: 25934513
    [Abstract] [Full Text] [Related]

  • 3. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X, Rui W, Wu C, He S, Jiang J, Zhang X, Yang Y.
    J Gastroenterol Hepatol; 2014 Jun 01; 29(6):1284-91. PubMed ID: 24329763
    [Abstract] [Full Text] [Related]

  • 4. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Wu C, Chen W, Fang M, Boye A, Tao X, Xu Y, Hou S, Yang Y.
    J Ethnopharmacol; 2019 Mar 01; 231():98-112. PubMed ID: 30412748
    [Abstract] [Full Text] [Related]

  • 5. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb 01; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

  • 6. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W, Xie L, Liu X, He S, Wu C, Zhang X, Zhang L, Yang Y.
    J Ethnopharmacol; 2014 Feb 01; 151(1):198-209. PubMed ID: 24247078
    [Abstract] [Full Text] [Related]

  • 7. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y, Yang S, Chen M, Zhang X, Zou Y, Zhang X.
    J Ethnopharmacol; 2008 Jul 23; 118(2):264-70. PubMed ID: 18502066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Compound Astragalus and Salvia miltiorrhiza extract suppresses rabbits' hypertrophic scar by modulating the TGF-β/Smad signal.
    Wu C, Jiang J, Boye A, Jiang Y, Yang Y.
    Dermatology; 2014 Jul 23; 229(4):363-8. PubMed ID: 25171116
    [Abstract] [Full Text] [Related]

  • 10. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ, Wang XH, Miao L, Liu Z, Zhang P, Zhang FM, Yang JB.
    World J Gastroenterol; 2006 Jan 28; 12(4):644-8. PubMed ID: 16489684
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X, Bellis S, Yan Z, Friedman E.
    Cell Growth Differ; 1999 Jan 28; 10(1):11-8. PubMed ID: 9950213
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
    Tao YY, Wang QL, Shen L, Fu WW, Liu CH.
    Exp Biol Med (Maywood); 2013 Nov 01; 238(11):1284-96. PubMed ID: 24006304
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G, Di Marcantonio MC, Artese L, Vianale G, Piccirelli A, Piccirilli M, Perrotti V, Rubini C, Piattelli A, Muraro R.
    Int J Oncol; 2008 Feb 15; 32(2):323-31. PubMed ID: 18202754
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.